ObesityGastroenterologyBiopharmaBiotechnologyHealth Care
Description
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines.
Business Segments
The company operates in multiple business segments which include research and development, colla…
Analysis
Hidden champion
Zealand Pharma A/S is what we call a hidden champion: a strong business that the market is not pricing as one. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is attractive. You pay 3.2× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone. At today's price, the market is assuming roughly -20% yearly growth; analysts expect -90%. The market is pricing in far more than analysts expect: heroic expectations.
The trajectory is tepid and the balance sheet is sturdy. The company scores 12/20 on our value-creation score: creating some value. Analyst sentiment is cautious.
What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 202617
40
2026
All-time high
40
Jun 2026
All-time low
17
Mar 2026
Average rank
29
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
41
—
—
—
Price/Earnings
9
—
—
—
Price/Book
50
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
9
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.